Total Payments
$7,262
2024 Payments
$210.09
Companies
32
Transactions
375
Medicare Patients
1,936
Medicare Billing
$386,433
Payment Breakdown by Category
Food & Beverage$7,224 (99.5%)
Education$37.52 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,224 | 371 | 99.5% |
| Education | $37.52 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,086 | 57 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $822.13 | 32 | $0 (2023) |
| Amarin Pharma Inc. | $749.44 | 39 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $580.17 | 19 | $0 (2020) |
| PFIZER INC. | $561.57 | 36 | $0 (2019) |
| Lilly USA, LLC | $525.22 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $470.43 | 25 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $403.78 | 14 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $353.89 | 19 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $264.20 | 24 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.09 | 10 | Amgen Inc. ($62.71) |
| 2023 | $183.47 | 9 | Exact Sciences Corporation ($36.16) |
| 2022 | $373.87 | 23 | Novartis Pharmaceuticals Corporation ($184.20) |
| 2021 | $397.32 | 25 | Amarin Pharma Inc. ($123.83) |
| 2020 | $760.54 | 46 | Amarin Pharma Inc. ($392.43) |
| 2019 | $1,564 | 76 | AstraZeneca Pharmaceuticals LP ($272.79) |
| 2018 | $1,980 | 109 | Novo Nordisk Inc ($429.24) |
| 2017 | $1,792 | 77 | AstraZeneca Pharmaceuticals LP ($363.77) |
All Payment Transactions
375 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation | ||||||
| 05/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes Care | ||||||
| 03/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Oncology | ||||||
| 02/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Inflammation | ||||||
| 10/18/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Oncology | ||||||
| 09/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiology | ||||||
| 07/31/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/05/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Oncology | ||||||
| 02/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/20/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2022 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Neurology | ||||||
| 11/11/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 608 | 2,384 | $528,694 | $189,082 |
| 2022 | 12 | 471 | 1,431 | $293,105 | $87,573 |
| 2021 | 7 | 262 | 490 | $141,725 | $31,331 |
| 2020 | 17 | 595 | 1,940 | $179,250 | $78,447 |
Total Patients
1,936
Total Services
6,245
Medicare Billing
$386,433
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 107 | 1,162 | $203,350 | $111,691 | 54.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 355 | $44,375 | $22,685 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 262 | $176,326 | $22,101 | 12.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 108 | 123 | $42,435 | $17,137 | 40.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 91 | 100 | $25,000 | $9,253 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 35 | $16,590 | $1,838 | 11.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $8,918 | $1,697 | 19.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 20 | $3,000 | $1,304 | 43.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 75 | $5,475 | $763.08 | 13.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $1,330 | $354.40 | 26.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $910.05 | $242.50 | 26.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 41 | 197 | $985.00 | $15.83 | 1.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 575 | $100,625 | $47,630 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 149 | $79,673 | $13,946 | 17.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 67 | $23,115 | $10,746 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 156 | $59,886 | $8,429 | 14.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 39 | 42 | $6,300 | $2,439 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $9,433 | $2,184 | 23.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 48 | 86 | $5,288 | $876.45 | 16.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $4,838 | $580.34 | 12.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 26 | 26 | $1,400 | $388.70 | 27.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 22 | 22 | $1,190 | $324.55 | 27.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 44 | 254 | $1,270 | $21.61 | 1.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 24 | $87.00 | $8.72 | 10.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 85 | 224 | $75,401 | $12,044 | 16.0% |
About Dr. Jorge Guerrero, MD
Dr. Jorge Guerrero, MD is a General Practice healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912015975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Guerrero, MD has received a total of $7,262 in payments from pharmaceutical and medical device companies, with $210.09 received in 2024. These payments were reported across 375 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,224).
As a Medicare-enrolled provider, Guerrero has provided services to 1,936 Medicare beneficiaries, totaling 6,245 services with total Medicare billing of $386,433. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Houston, TX
- Active Since 08/29/2006
- Last Updated 08/08/2024
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1912015975
Products in Payments
- Vascepa (Drug) $749.44
- JARDIANCE (Drug) $663.31
- FARXIGA (Drug) $614.66
- Ozempic (Drug) $448.80
- XIFAXAN (Drug) $389.73
- TRELEGY ELLIPTA (Drug) $360.47
- Victoza (Drug) $347.99
- ENTRESTO (Drug) $315.36
- EUCRISA (Drug) $309.50
- TOUJEO (Drug) $248.64
- TRULICITY (Drug) $205.11
- Tresiba (Drug) $155.51
- TRADJENTA (Drug) $154.39
- BYDUREON (Drug) $149.39
- NAMENDA XR (Drug) $143.45
- LONHALA MAGNAIR (Drug) $130.69
- SOLIQUA 100/33 (Drug) $121.34
- TOVIAZ (Drug) $117.89
- Utibron (Drug) $117.13
- Cologuard Collection Kit (Device) $73.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Houston
Kathleen Szelei-Stevens, M.d, M.D
General Practice — Payments: $181,094
General Practice $181,094
Dr. Scott Coleman, D.d.s, D.D.S
General Practice — Payments: $133,837
General Practice $133,837
Dr. Kenneth Lepow, Dds, Dmd, Pa, DDS, DMD, PA
General Practice — Payments: $50,182
General Practice $50,182
Terri Alani, Dds, DDS
General Practice — Payments: $48,761
General Practice $48,761
Dr. Robert Paisley, M.d, M.D
General Practice — Payments: $46,830
General Practice $46,830
Matthew Segar, Md, MD
General Practice — Payments: $44,912
General Practice $44,912